Key Takeaways
- Record profit on supply shock, not volume: EBITDA surged 188% YoY as the West Asia crisis choked styrene supply and blew out global product deltas (GPPS $300+, HIPS $400+), while volumes fell 25% because exports collapsed and non-OEM demand evaporated.
- The margin spike is an aberration, not a reset: Management called Q1 margins an "aberration" driven by exceptionally wide global deltas and expects normalization over time; the base price of polystyrene tracks global trends, so weaker deltas mean weaker margins.
- Non-OEM demand is already returning: Nearly 50% of non-OEM demand vanished in Q1 on price resistance, but in the current quarter those buyers have reconciled to higher prices and demand is back in the market.
- Three-year capacity build underway, funded internally: Board approved a new 80,000 TPA polystyrene line (Dec 2028), plus EPS board and compounding expansions (Jun 2027), all from internal accruals; the thesis rests on long-term India demand growth and export possibilities, not one-quarter events.
- What to watch next quarter: Whether the non-OEM demand recovery translates into volume, how quickly global styrene-to-product deltas compress from Q1's extreme levels, and any signal on EPS export resumption if Red Sea shipping normalizes.
The West Asia Supply Shock
- Unprecedented regional disruption: All three styrene plants in the Gulf region suspended operations due to safety reasons from geopolitical tensions and Strait of Hormuz cargo disruptions, a prolonged full-region outage that management says has no parallel in past force majeure events or even COVID.
- Alternate sourcing came at a structural cost: The company established alternate supply arrangements and met all domestic customer requirements without interruption, but non-Gulf sourcing carries permanently higher freight from longer voyage times (Gulf is 4–7 days) and reduced shipping availability.
- Exports were sacrificed to protect domestic supply: EPS exports took a back seat for four months due to Red Sea disturbances, sharply higher freight rates, increased voyage time, and limited styrene monomer availability; focus shifted entirely to meeting domestic demand.
- Import duty suspension compounded the domestic challenge: Temporary suspension of import duties on commodity polymers led to unnecessarily increased imports, eroding market share for domestic producers at a time when they were already supply-constrained.
Nayyar: "It is entirely a different situation because in the past, some plants may shut down because of some force majeure conditions, break down other things. There could be very small constraints of supply chain but here it is a prolonged and from full region. It is not one plant, one source but it is a full region from where the material is not coming in and even during COVID times, this situation was not there. This is entirely a different scenario, not comparable to the past events at all."
Margin Mechanics: Why Q1 Was Exceptional
- Global deltas drove the profit surge: The 188% YoY EBITDA jump was driven entirely by widening international deltas between styrene monomer and downstream products (GPPS, HIPS), not by volume growth; volumes actually fell 25% YoY.
- The aberration label: Management explicitly called Q1 margins an "aberration" because global deltas were exceptionally strong (GPPS USD300+, HIPS USD400+), and stated these aberrations will normalize over time as global deltas return to normal.
- Margin outlook is deliberately unguided: Management declined to hazard any guess on sustainable margin figures for FY27 or FY28, citing a fluid situation with supply chain issues, the need to source from different markets, and unpredictable global deltas.
- Specialty grades provide a structural cushion: The company has certain specialized grades that always fetch better prices than industry prices.
Nayyar: "This margin which has come in, is like an aberration because of the global deltas were very-very strong... Those aberrations will get normalized over a period of time."
Demand Split: OEM Stable, Non-OEM Volatile
- OEM demand held firm: OEM segment demand was good and stable throughout Q1, with no price resistance issue; appliance manufacturers are setting up large capacities for exports under the PLI scheme, and during peak months existing capacity is already used to the fullest extent.
- Non-OEM demand collapsed then recovered: Almost 50% of non-OEM demand evaporated in Q1, partly because of high prices and partly because downstream processors had gas supply availability issues; in the current quarter (Q2 FY27), non-OEMs have reconciled to higher prices as a global phenomenon and demand is back.
- Volume decline was industry-wide: The 25% YoY volume decline was at par with the industry for polystyrene; for EPS, de-growth was less than smaller fragmented players in North India.
- Import data is now unavailable: The government issued a notification in March making the publication of import data a crime, so authentic import data is not available to assess competitive import pressure.
Nayyar: "The base price of polystyrene and other polymers is all decided keeping in view the global trends if global deltas are strong, we also will have better margins if global deltas are weak or..."
Capacity Expansion: Betting on India's Long-Term Story
- Three projects approved, all internally funded: Board approved a new 80,000 TPA polystyrene production line at Amdoshi (Dec 2028), a wide-width EPS board line of 150,000 cubic meters (Jun 2027), and compounding capacity expansion from 50,000 TPA to 80,000 TPA (Jun 2027); total estimated investment of ₹450 crores funded entirely through internal accruals.
- The rationale is structural, not cyclical: Management emphasized that a project is not set up for temporary events of one quarter; the decision rests on long-term India demand growth, export possibilities, and the country's trajectory as a manufacturing hub.
- Compounding pivot toward ABS: The company is now moving more toward ABS compounds and is setting up lines mainly for ABS compounds, seeing significant growth there; the aim is to exhaust expanded compounding capacity over 2–3 years after commissioning.
- Credit discipline will govern compounding growth: Strategy for ABS compounds will focus on value-added customers and segments requiring lower credit; the company will not supply where credit discipline is absent, even if that means slower growth.
- EPS exports to Europe are a real option: EPS grades have been approved in Europe and small quantities were exported last year; once the situation normalizes and shipping opens up, the company will certainly export EPS, particularly to European markets.
Nayyar: "A project is not set up for the temporary events of one quarter. Picture on a long term basis and where the industry is going, where India is going, where Indian demand is growing and what are the export possibilities going forward has to be kept in mind..."
What Management Would Not Answer
- No volume guidance: Management declined to give any volume guidance or ballpark number for FY27, stating the situation is very fluid with West Asian uncertainty, styrene availability, and shipping concerns; they will take it as the quarters go by until the situation becomes very normal.
- No margin guidance: When asked for a sustainable margin figure or range for FY27 and FY28, management gave only a general answer about global deltas and declined to provide any specific number.
- No ABS volume disclosure: Management declined to share ABS volumes separately, stating it is all styrenics business and they do not give separate volume numbers.
- No ABS market size data: When asked for overall industry demand for ABS-based compounds, management stated they did not have ready numbers for the ABS compounds market.
Nayyar: "It's very difficult to say because the whole situation is fluid. We have to go to different markets to source raw material, the global deltas, supply chain issues are there, so I wouldn't hazard any guess right now in terms of the volume. We know that we can handle the situations well."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EPS board line and compounding expansion commissioned | 150,000 m³ wide-width EPS board line; compounding capacity expanded from 50,000 to 80,000 TPA | June 2027 |
| New polystyrene production line commissioned | 80,000 TPA line at Amdoshi complex, Maharashtra | December 2028 |
| Compounding capacity fully utilized | Expanded 80,000 TPA capacity sold out | 2–3 years after June 2027 commissioning |
| ABS compounding capacity fully sold out | Capacity being built to be fully absorbed by market demand | 3–4 years |
| EPS exports to Europe resume | Exports restart once shipping normalizes and Red Sea situation opens up | Conditional on situation normalization |
| All CAPEX funded internally | ₹450 crores total investment from internal accruals | Ongoing through project completion |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹1,693 cr, +22% YoY |
| Operating EBITDA | ₹331 cr, +188% YoY |
| Operating EBITDA margin | 19.53%, vs 8.3% in Q1 FY26 (per an analyst's math) |
| Total EBITDA (incl. other income) | ₹348 cr, margin of 20.3% |
| Net profit after tax | ₹236 cr, PAT margin of 13.96% |
| Sales volume (manufactured products) | 70,842 MT, -24.5% YoY |
| Exports | 10–12% of normal quarterly export volume (management statement) |
| Trading sales share | 17–18% of top line |
| Non-OEM sales decline | ~50% (management statement) |
| Polystyrene imports (market estimate) | ~20,000 tons in Q1 (management statement) |
| Styrene monomer price (CIF India, current) | ~USD 1,300 |
| Styrene monomer price range (Q1) | ~USD 1,350–1,400, peak at USD 1,500+ |
| GPPS global delta (current) | ~USD 250–275 |
| HIPS global delta (current) | ~USD 350 |
| Total capex for announced expansions | ~₹900 cr, funded via internal accruals (management statement) |